<!DOCTYPE html>
<html>
    <head>
        <title>STD Tx Guidelines</title>
    </head>
    <body>
        <!-- Start of page -->
        <div data-role="page" id="g282" data-theme="a">
            <div data-role="header" data-id="guidelines-header" data-theme="b" data-position="fixed">
                <a href="lv-280.html" class="ui-btn ui-icon-back ui-btn-icon-notext ui-corner-all" aria-label="back"></a>
                <h3>STD Tx Guidelines</h3>
                <a href="#nav-panel" class="ui-btn ui-icon-bars ui-btn-icon-notext ui-corner-all" aria-label="main menu"></a>
            </div>
            <div data-role="content">
            <div id=guidelines_breadcrumbs>
            
                    <a href="lv-262.html" >Full Guidelines</a><span class="carrot"> > </span>
                    <a href="lv-279.html" >Diseases Characterized by Vaginal Discharge</a><span class="carrot"> > </span>
                    <a href="lv-279.html" >Vulvovaginal Candidiasis</a><span class="carrot"> > </span>
                    <a href="lv-280.html" >Uncomplicated VVC</a><span class="carrot"> > </span>Treatment
            </div>
            </br><h4 class="sgc-1" id="sigil_toc_id_282">
 Treatment
</h4>
<p>
 Short-course topical formulations (i.e., single dose and regimens&nbsp;of 1&ndash;3 days) effectively treat uncomplicated VVC. The&nbsp;topically applied azole drugs are more effective than nystatin. Treatment with azoles results in relief of symptoms and negative cultures in 80%&ndash;90% of patients who complete therapy.
</p>
<p>

        <div id="table">
            <div id="regimen_header">Recommended Regimen
            </div>
            <hr/>
            <span class="regimen_text"></br>
                <div id="regimen_subheader">Over-the-Counter Intravaginal Agents:</br></div>Butoconazole 2% cream 5 g intravaginally for 3 days
            <div id="or">OR</div>Clotrimazole 1% cream 5 g intravaginally for 7â€“14 days
            <div id="or">OR</div>Clotrimazole 2% cream 5 g intravaginally for 3 days
            <div id="or">OR</div>Miconazole 2% cream 5 g intravaginally for 7 days
            <div id="or">OR</div>Miconazole 4% cream 5 g intravaginally for 3 days
            <div id="or">OR</div>Miconazole 100 mg vaginal suppository, one suppository for 7 days
            <div id="or">OR</div>Miconazole 200 mg vaginal suppository, one suppository for 3 days
            <div id="or">OR</div>Miconazole 1,200 mg vaginal suppository, one suppository for 1 day
            <div id="or">OR</div>Tioconazole 6.5% ointment 5 g intravaginally in a single application</br>
                <div id="regimen_subheader">Prescription Intravaginal Agents:</br></div>Butoconazole 2% cream (single dose bioadhesive product), 5 g intravaginally for 1 day
            <div id="or">OR</div>Nystatin 100,000-unit vaginal tablet, one tablet for 14 days
            <div id="or">OR</div>Terconazole 0.4% cream 5 g intravaginally for 7 days
            <div id="or">OR</div>Terconazole 0.8% cream 5 g intravaginally for 3 days
            <div id="or">OR</div>Terconazole 80 mg vaginal suppository, one suppository for 3 days</br>
                <div id="regimen_subheader">Oral Agent:</br></div>Fluconazole 150 mg oral tablet, one tablet in single dose
            </span>

        </div>
 <br/>
</p>
<p>
 The creams and suppositories in this regimen are oil-based and might weaken latex condoms and diaphragms. Patients and providers should refer to condom product labeling for further information.
 <br/>
</p>
<p>
 Intravaginal preparations of butaconazole, clotrimazole, miconazole, and tioconazole are available over-the-counter (OTC). Women whose condition has previously been diagnosed&nbsp;with VVC are not necessarily more capable of diagnosing themselves; therefore, any woman whose symptoms persist after using an OTC preparation or who has a recurrence of symptoms&nbsp;within 2 months should be evaluated with office-based testing. Unnecessary or inappropriate use of OTC preparations is common and can lead to a delay in the treatment of other&nbsp;vulvovaginitis etiologies, which can result in adverse clinical outcomes.
</p>
<p>
</p>

            </div>
        <div data-role="panel" data-display="push" data-theme="b" id="nav-panel">
            <ul data-role="listview">
                <li data-icon="delete"><a href="#" data-rel="close">Close menu</a></li>
                <li><a href="../conditions/c0-clv.html">Condition Quick Pick</a></li>
                <li><a href="../guidelines/lv-0.html">Full STD Tx Guidelines</a></li>
                <li><a href="../page/hx-pdf.html">Taking a Sexual Hx PDF</a></li>
                <li><a href="../terms/1.html">Terms and Abbreviations</a></li>
                <li><a href="../refs/lv-0.html">References</a></li>
                <li><a href="../page/about_us.html">About Us</a></li>
            </ul>
        </div><!-- /panel -->
    
        </div>
        <!-- end of guidelines heading page -->
    </body>
</html>
    